WVE - Wave Life Sciences Ltd.
NEXT EARNINGS:
Mar 3, 2026
(in 6 days)
EPS Est: $-0.28
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.00
DETAILS
HIGH:
$50.00
LOW:
$26.00
MEDIAN:
$30.00
CONSENSUS:
$32.00
UPSIDE:
128.25%
Market Cap:
2.57B
Volume:
2,993,182
Avg Volume:
6,931,930
52 Week Range:
5.28-21.73
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-1.77
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
SG
Employees:
287
IPO Date:
2015-11-11
EPS (TTM):
-0.70
P/E Ratio:
-17.63
Revenue (TTM):
108.30M
Total Assets:
352.21M
Total Debt:
25.40M
Cash & Equiv:
302.08M
Rev Growth (5Y):
46.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-45.8%
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.32 | $-0.30 | -6.7% | $7.6M | $17.3M | -55.9% |
| 2025-07-30 | $-0.31 | $-0.29 | -6.9% | $8.7M | $9.8M | -11.7% |
| 2025-05-08 | $-0.29 | $-0.27 | -7.4% | $9.2M | $14.4M | -36.4% |
| 2025-03-04 | $0.17 | $-0.17 | +200.0% | $83.7M | $12.2M | +588.3% |
| 2024-11-12 | $-0.47 | $-0.28 | -67.9% | $-7676000 | $25.6M | -130.0% |
| 2024-08-08 | $-0.25 | $-0.16 | -56.2% | $19.7M | $24.3M | -19.1% |
| 2024-05-09 | $-0.24 | $-0.18 | -33.3% | $12.5M | $22.9M | -45.4% |
| 2024-03-06 | $-0.15 | $-0.19 | +21.1% | $29.1M | $19.9M | +46.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 108.30M | 113.31M | 3.65M | 40.96M | 20.08M | 15.98M | 14.41M | 3.70M | 1.49M | 152,000 | 0 | 0 |
| Net Income | (97.01M) | (57.51M) | (161.82M) | (122.25M) | (149.91M) | (193.64M) | (146.65M) | (102.03M) | (55.40M) | (19.20M) | (5.23M) | (3.32M) |
| EPS | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| Total Assets | 352.21M | 274.95M | 146.39M | 207.01M | 279.24M | 284.25M | 295.94M | 181.84M | 164.81M | 165.42M | 2.94M | 2.32M |
| Total Debt | 25.40M | 32.12M | 37.61M | 29.92M | 29.30M | 32.55M | 10.40M | 3.45M | 78,000 | 140,000 | 0 | 9.60M |
| Cash & Equivalents | 302.08M | 200.35M | 88.50M | 150.56M | 184.50M | 147.16M | 174.82M | 142.50M | 150.29M | 161.22M | 1.05M | 439,000 |
| Operating Cash Flow | (151.03M) | (19.43M) | (127.78M) | (88.99M) | (115.98M) | (188.23M) | (22.86M) | (83.67M) | (31.87M) | (12.53M) | (4.43M) | (3.55M) |
| Free Cash Flow | (151.96M) | (20.55M) | (129.14M) | (89.55M) | (117.32M) | (192.15M) | (32.80M) | (102.56M) | (37.44M) | (14.38M) | (5.02M) | (3.60M) |
| FCF per Share | -1.10 | -0.19 | -1.64 | -1.73 | -2.99 | -5.67 | -1.13 | -3.87 | -1.64 | -0.67 | -0.24 | -1.01 |
| Book Value | 209.51M | 39.63M | (45.09M) | 32.50M | 90.65M | 71.61M | 73.35M | 139.81M | 134.86M | 153.49M | 2.03M | (7.76M) |
| Cash & ST Investments | 302.08M | 200.35M | 88.50M | 150.56M | 184.50M | 147.16M | 174.82M | 142.50M | 150.29M | 161.22M | 1.05M | 439,000 |
| ROC Equity | -0.46 | -1.45 | N/A | -3.76 | -1.65 | -2.70 | -2.00 | -0.73 | -0.41 | -0.13 | -2.58 | N/A |